For this purpose we employed 10E1-CEM (Bcl-2 overexpressing cells) and R5-CEM cells, both derived from the human leukemia CEM native cell line and resistant to antineoplastic drug 4-HPR, among others [30–32]. The gene discussed is BCL2; the disease is leukemia.